Skip to main content

Loading market data...

NHI

National Health Investors, Inc.

NYSE • United states

$64.92

-$1.43

(-2.16%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

National Health Investors, Inc. (NHI)

Unavailable

Quotes may be delayed

$3.19B

Market Cap

247,474

Volume

19.1

P/E Ratio

5.60%

Div Yield

National Health Investors, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 222 ROBERT ROSE DRIVE, MURFREESBORO, TN
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

27 Aug 2026

National Health Investors, Inc. reported A director or senior management change or compensation event

National Health Investors, Inc. filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.

10 Aug 2026

National Health Investors, Inc. reported Regulation FD disclosure

National Health Investors, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

10 Aug 2026

National Health Investors, Inc. reported Regulation FD disclosure

National Health Investors, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

10 Aug 2026

National Health Investors, Inc. reported Operating or financial results

National Health Investors, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

10 Aug 2026

National Health Investors, Inc. filed Form 10-Q

National Health Investors, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$30.39M

Total assets (USD)$2.96B

Total liabilities (USD)$1.37B

Shareholders' equity (USD)$1.57B

Long-term debt (USD)$1.13B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Real Estate

Company	Price	Market Cap
WELL - Welltower Inc.	$235.98 Yahoo Finance	$170.08B
PLD - Prologis, Inc.	$128.69 Yahoo Finance	$122.01B
BN - Brookfield Corporation	$37.54 Yahoo Finance	$92.00B
AMT - American Tower Corporation	$180.61 Yahoo Finance	$84.16B
BAM - Brookfield Asset Management Ltd.	$45.93 Yahoo Finance	$73.36B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$44.78M	Unavailable	$55.67M	$1.15	10-Q · 10 Aug 2026
Q1 2026	$37.06M	Unavailable	$40.10M	$0.82	10-Q · 4 May 2026
Q4 2025	$30.73M	Unavailable	$38.16M	Unavailable	10-K · 26 Feb 2026
Q3 2025	$21.18M	Unavailable	$32.86M	$0.69	10-Q · 6 Nov 2025
Q2 2025	$14.22M	Unavailable	$36.99M	$0.79	10-Q · 6 Aug 2025
Q1 2025	$13.94M	Unavailable	$34.17M	$0.74	10-Q · 5 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $80.50

24.0% upside potential

📈

Strong Buy

Unavailable

👍

Buy

5

⏸️

Hold

1

📉

Sell

0

6 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 22 Oct 2026, 00:47 UTC Targets range 68.00–90.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

27

Jul 2026

Maingot Christian Ken

Chief Operating Officer

Grant or award

Unavailable per share

2,370 shares

15

Jun 2026

MCCABE ROBERT A JR

Director

Open-market purchase

$71.65 per share

890 shares

5

Jun 2026

Jobe James R

Director

Gift

Unavailable per share

225 shares

5

Jun 2026

Mendelsohn D. Eric

Director, CEO and President

Open-market purchase

$68.84 per share

1,500 shares

5

May 2026

Spaid John L

CFO/EVP Finance

Tax withholding

$73.09 per share

314 shares

5

May 2026

Mendelsohn D. Eric

Director, CEO and President

Tax withholding

$73.09 per share

394 shares

5

May 2026

Travis David L

SVP/Chief Accounting Officer

Tax withholding

$73.09 per share

282 shares

3

Mar 2026

PASCOE KEVIN CARLTON

Chief Investment Officer

Grant or award

Unavailable per share

4,726 shares

Top Shareholders

Blackrock, Inc.

8,733,237 shares

81.683% change

6/30/2026

Vanguard Group Inc

6,496,852 shares

-0.024% change

12/31/2025

Vanguard Portfolio Management Llc

4,630,646 shares

11.792% change

6/30/2026

State Street Corp

2,735,937 shares

38.571% change

6/30/2026

Vanguard Capital Management Llc

2,099,145 shares

0.697% change

6/30/2026

Principal Financial Group Inc

1,977,094 shares

16.238% change

6/30/2026

Bank Of New York Mellon Corp

1,606,463 shares

212.098% change

6/30/2026

Geode Capital Management, Llc

1,402,775 shares

6.981% change

6/30/2026

Bank Of America Corp /De/

1,019,379 shares

2.677% change

6/30/2026

Charles Schwab Investment Management Inc

880,321 shares

6.578% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 22 Oct 2026, 00:47 UTC· 6 hours ago

Research coverage and investment tools

National Health Investors, Inc. (NHI) is a stock listed on the New York Stock Exchange in the United States, in the Real Estate sector (Real Estate Investment Trusts). Its last price was US$64.92 on 21 Oct 2026. That is 5% of the way from its 52-week low of US$63.51 to its 52-week high of US$91.38. It paid US$3.70 a share in dividends over the last 12 months, a dividend yield of 5.60%. The latest ex-dividend date on file is 30 Sep 2026. Its market capitalisation was US$3.19 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$44.78M	Unavailable	$55.67M	$1.15	—	—	—	10-Q · 10 Aug 2026 (opens in a new tab)
Q1 2026	$37.06M	Unavailable	$40.10M	$0.82	—	—	—	10-Q · 4 May 2026 (opens in a new tab)
Q4 2025	$30.73M	Unavailable	$38.16M	Unavailable	—	—	—	10-K · 26 Feb 2026 (opens in a new tab)
Q3 2025	$21.18M	Unavailable	$32.86M	$0.69	—	—	—	10-Q · 6 Nov 2025 (opens in a new tab)
Q2 2025	$14.22M	Unavailable	$36.99M	$0.79	—	—	—	10-Q · 6 Aug 2025 (opens in a new tab)
Q1 2025	$13.94M	Unavailable	$34.17M	$0.74	—	—	—	10-Q · 5 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/10/2026	$1.19	$1.26	-5.6%
Mar 2026	5/4/2026	$1.24	$1.21	+2.5%
Dec 2025	2/26/2026	$1.22	$1.23	-0.8%
Sep 2025	11/6/2025	$1.32	$1.24	+6.5%

Cash and equivalents: $30.39M
Total assets: $2.96B
Total liabilities: $1.37B
Shareholders' equity: $1.57B
Long-term debt: $1.13B

8-K · 27 Aug 2026 · Management change

National Health Investors, Inc. reported A director or senior management change or compensation event (opens in a new tab)

National Health Investors, Inc. filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.
8-K · 10 Aug 2026

National Health Investors, Inc. reported Regulation FD disclosure (opens in a new tab)

National Health Investors, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 10 Aug 2026

National Health Investors, Inc. reported Regulation FD disclosure (opens in a new tab)

National Health Investors, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 10 Aug 2026

National Health Investors, Inc. reported Operating or financial results (opens in a new tab)

National Health Investors, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
10-Q · 10 Aug 2026

National Health Investors, Inc. filed Form 10-Q (opens in a new tab)

National Health Investors, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

Insider	Date	Transaction	Shares	Average price	Filing
Maingot Christian Ken Chief Operating Officer	27 Jul 2026	Grant or award (A)	+2,370	—	Form 4 (opens in a new tab)
MCCABE ROBERT A JR Director	15 Jun 2026	Open-market purchase (P)	+890	$71.65	Form 4 (opens in a new tab)
Jobe James R Director	5 Jun 2026	Gift (G)	−225	—	Form 4 (opens in a new tab)
Mendelsohn D. Eric Director, CEO and President	5 Jun 2026	Open-market purchase (P)	+1,500	$68.84	Form 4 (opens in a new tab)
Spaid John L CFO/EVP Finance	5 May 2026	Tax withholding (F)	−314	$73.09	Form 4 (opens in a new tab)
Mendelsohn D. Eric Director, CEO and President	5 May 2026	Tax withholding (F)	−394	$73.09	Form 4 (opens in a new tab)
Travis David L SVP/Chief Accounting Officer	5 May 2026	Tax withholding (F)	−282	$73.09	Form 4 (opens in a new tab)
PASCOE KEVIN CARLTON Chief Investment Officer	3 Mar 2026	Grant or award (A)	+4,726	—	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	8,733,237	81.683%
Vanguard Group Inc	12/31/2025	6,496,852	-0.024%
Vanguard Portfolio Management Llc	6/30/2026	4,630,646	11.792%
State Street Corp	6/30/2026	2,735,937	38.571%
Vanguard Capital Management Llc	6/30/2026	2,099,145	0.697%
Principal Financial Group Inc	6/30/2026	1,977,094	16.238%
Bank Of New York Mellon Corp	6/30/2026	1,606,463	212.098%
Geode Capital Management, Llc	6/30/2026	1,402,775	6.981%
Bank Of America Corp /De/	6/30/2026	1,019,379	2.677%
Charles Schwab Investment Management Inc	6/30/2026	880,321	6.578%

Previous close: 66.35 USD
Day range: 64.74 – 66.89 USD
52-week range: 63.51 – 91.38 USD
Volume: 247,474
Market cap: $3.19B
Average volume: 297,333
P/E ratio: 19.1
EPS (FY 2025, diluted): 3.02 USD
Dividends (last 12 months): 3.70 USD
Dividend yield: 5.60%
Ex-dividend date: 30 Sep 2026
Shares outstanding: 49.11M
Beta (5Y monthly): 0.51

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:00 UTC· 11 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:38 UTC· 37 minutes ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:38 UTC· 37 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for NHI yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.